Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Labcorp Holdings Inc. (LH) P/S ratio

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/S ratio of 1.8×. Over the past ten years it has ranged from 0.8× (March 2020) to 2.0× (December 2021); the current reading is higher than 98% of that period. That is below the Diagnostics & Research industry median of 4.9× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 1.5× 1.16%
FY2024 1.5× (11.20%)
FY2023 1.7× 6.18%
FY2022 1.6× (21.06%)
FY2021 2.0× 63.25%
FY2020 1.2× (1.15%)
FY2019 1.2× 26.78%
FY2018 1.0× (29.88%)
FY2017 1.4× 16.42%
FY2016 1.2× (1.60%)

Quarterly

Period P/S ratio Change
Jun 2026 1.6× 2.70%
Mar 2026 1.6× 3.77%
Dec 2025 1.5× (13.67%)
Sep 2025 1.7× 6.73%
42 more quarters

Against its own ten years

Low 0.8× High 2.0×
Ten-year median 1.4×
Current reading's percentile 98

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LH